HopeStage
Back to all studies
CompletedNCT00060814

Combined medication and behavioral support to help methadone patients stop smoking

About this titleRead the official source — NCT00060814
Interventional studyAges 18–70United StatesAddiction
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 70 years.

Listed locations
Kansas CitySee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateJune 2002
Recruitment status
Completed
Enrollment listed in the registry
28
Sponsor
National Institute on Drug Abuse (NIDA)
Sponsor type
Research institute
Study type
Other
Intervention type
Other
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United States
Age range
From 18 Years to 70 Years
Official registry ID
NCT00060814
Official title
Show the full official title

Pilot Study Examining the Effects of Combined Pharmacotherapy (Zyban/NRT)/Behavioral Treatment on Smoking Cessation Among MMT Patients.

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Kansas City

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is National Institute on Drug Abuse (NIDA), a research institute.

Who was this study for?

Listed age limits: 18 years to 70 years.

Want to explore more studies?

Explore studies